Nalaganje...
OX40 (CD134) and OX40 ligand, important immune checkpoints in cancer
Immunotherapy has shown promising results in cancer treatment. Research shows that most patients might be resistant to these therapies. So, new immune therapies are needed. OX40 (CD134) and OX40 ligand (OX40L), costimulatory molecules, express on different types of immune cells. The interaction betw...
Shranjeno v:
| izdano v: | Onco Targets Ther |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6735535/ https://ncbi.nlm.nih.gov/pubmed/31564917 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S214211 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|